急性冠脉综合征抗栓治疗进展

Development of Antithrombotic Therapy for Acute Coronary Syndrome

抗栓在急性冠脉综合征的治疗中占有非常重要的地位,它包括抗血小板治疗和抗凝血酶治疗。随着大规模临床试验的公布,新药的不断开发,急性冠脉综合征患者的预后得到显著改善,为临床带来了更多的希望。因此,临床医生应该更多的重视抗栓治疗。

The use of antithrombosis drugs is very important in the treatment of patients with acute coronary syndrome （ ACS）. Two drug agents, an antiplatelet agent and an antithrombin agent, are routinely utilised in clinical trials for antithrombosis. In a large number of published clinical trials, including many trials of new drugs, the prognosis for survival after ACS is improved. Antithrombotic therapy deserves more attention from physicians.